FRANKFURT (Reuters) -Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion (NASDAQ:ALXN) Pharmaceuticals for $39 billion in its largest ever deal, diversifying away from its fast-growing cancer business in a…
Trending News
December 20, 2025
December 9, 2025
November 28, 2025
November 28, 2025
October 22, 2025





